Business Description
CanBas Co Ltd
ISIN : JP3244570002
Total Employee Number:
14Description
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12.6 | |||||
3-Year EPS without NRI Growth Rate | 11.5 | |||||
3-Year FCF Growth Rate | 18.2 | |||||
3-Year Book Growth Rate | 90.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.12 | |||||
9-Day RSI | 78.71 | |||||
14-Day RSI | 73.56 | |||||
3-1 Month Momentum % | -25.23 | |||||
6-1 Month Momentum % | -37.43 | |||||
12-1 Month Momentum % | -45.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.94 | |||||
Quick Ratio | 15.94 | |||||
Cash Ratio | 13.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -38.69 | |||||
ROA % | -37.03 | |||||
ROIC % | -588.96 | |||||
3-Year ROIIC % | -316.5 | |||||
ROC (Joel Greenblatt) % | -1184.3 | |||||
ROCE % | -38.99 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 7.56 | |||||
Price-to-Tangible-Book | 7.56 | |||||
EV-to-EBIT | -14.1 | |||||
EV-to-EBITDA | -14.1 | |||||
EV-to-FCF | -17.07 | |||||
| Price-to-Net-Current-Asset-Value | 7.93 | |||||
| Price-to-Net-Cash | 9.6 | |||||
Earnings Yield (Greenblatt) % | -7.1 | |||||
FCF Yield % | -4.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CanBas Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -50.04 | ||
| Beta | -0.398 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.34 | ||
| Volatility % | 46.67 | ||
| 14-Day RSI | 73.56 | ||
| 14-Day ATR (円) | 41.821052 | ||
| 20-Day SMA (円) | 637.35 | ||
| 12-1 Month Momentum % | -45.89 | ||
| 52-Week Range (円) | 506 - 1558 | ||
| Shares Outstanding (Mil) | 19.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CanBas Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CanBas Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
CanBas Co Ltd Frequently Asked Questions
What is CanBas Co Ltd(TSE:4575)'s stock price today?
The current price of TSE:4575 is 円796.00. The 52 week high of TSE:4575 is 円1558.00 and 52 week low is 円506.00.
When is next earnings date of CanBas Co Ltd(TSE:4575)?
The next earnings date of CanBas Co Ltd(TSE:4575) is .
Does CanBas Co Ltd(TSE:4575) pay dividends? If so, how much?
CanBas Co Ltd(TSE:4575) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CanBas Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers